Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced Constipation
Jan Tack(KU Leuven), James Wild(Williams (United States)), Lynn R. Webster(Adherent Technologies (United States)), M. Hale, Michael Camilleri(CSIRO Manufacturing), Bart Morlion(KU Leuven), Srinivas Nalamachu
Cited by 12
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Intestinal barrier function in health and gastrointestinal disease
|Neurogastroenterology & Motility|2012|886
Pneumatic Dilation versus Laparoscopic Heller's Myotomy for Idiopathic Achalasia
|New England Journal of Medicine|2011|852